“In silico Design and Computational Assessment of Small-Molecule GLP-1R Agonist as a Possible Treatment for Obesity and Type 2 Diabetes” (2026) Tikrit Journal of Pharmaceutical Sciences, 20(1), pp. 51–66. doi:10.25130/tjphs.2026.20.1.6.51.66.